Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9Q9P

TRIM21 PRYSPRY bound to compound 37

これはPDB形式変換不可エントリーです。
9Q9P の概要
エントリーDOI10.2210/pdb9q9p/pdb
分子名称E3 ubiquitin-protein ligase TRIM21, (2~{S},4~{S})-1-[(3~{S})-3-azanyl-3-(2-methoxyphenyl)propanoyl]-4-cyclohexyl-~{N}-[(2~{S})-1-(methylamino)-1-oxidanylidene-3-pyridin-4-yl-propan-2-yl]pyrrolidine-2-carboxamide (3 entities in total)
機能のキーワードtrim21, e3 ligase, protac, pryspry, ligase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計23053.91
構造登録者
Luptak, J. (登録日: 2025-02-26, 公開日: 2025-10-08, 最終更新日: 2026-04-22)
主引用文献Luptak, J.,Clift, D.,Mukadam, A.,Benn, J.,Rhinesmith, T.,McLaughlin, S.H.,Dodds, A.C.,Lapetaje, J.E.,Sczaniecka-Clift, M.,France, D.J.,McEwan, W.A.,James, L.C.
State-selective small molecule degraders that preferentially remove aggregates and oligomers.
Nat Commun, 16:10486-10486, 2025
Cited by
PubMed Abstract: TRIM21 is a unique E3 ligase that uses a clustering-based activation mechanism to degrade complex multimeric substrates. This activity underpins the targeted protein degradation technology Trim-Away and genetically encoded degraders that selectively target aggregated tau protein and prevent tauopathy. Here we describe small molecules that mimic TRIM21's natural epitope and function as either effective inhibitors or potent and selective degraders called TRIMTACs. TRIMTACs mediate degradation as rapidly as PROTACs but can also selectively degrade specific protein pools depending on assembly state. We demonstrate the utility of this state-specific degradation by selectively removing the pro-inflammatory signalling protein Myd88 when assembled into the Myddosome and the cell-death protein RIPK3 when polymerised into the Necrosome. We further show that TRIMTACs can inhibit seeded tau aggregation under conditions where a PROTAC is ineffective. These results highlight that TRIM21's clustering-based activation can be exploited by small molecule degraders to carry out state-selective degradation of therapeutic targets.
PubMed: 41290659
DOI: 10.1038/s41467-025-65454-z
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.1 Å)
構造検証レポート
Validation report summary of 9q9p
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon